Stubbs JR, House JA, Ocque AJ, et al
Zhu X, Zhu Y, Li C, Yu J, Ren D, Qiu S, Nie Y, Yu X, Xu X, Zhu W
The GLP-1 Showdown: Ozempic vs Mounjaro Head-to-Head Comparison Diabetes Specialists Compare A1C Reduction, Weight Loss Results, Side Effects, and Organ Protection Benefits in This 'GLP-1 Showdown In this video, you will learn about the following: Head-to-head comparison of A1C reduction and weight loss benefits (up to 20%) Heart and kidney protection benefits which medication has more substantial evidence Managing side effects and finding the right dosing strategy for your needs Latest research on additional benefits, including sleep apnea improvement Considerations for long-term treatment success Endocrinologists Dr
GLP-1 RAs exert an antihyperglycemic effect by enhancing pancreatic -cellmediated glucose-dependent insulin secretion, suppressing glucagon secretion, delaying gastric emptying, and reducing food intake in patients with T2D [6]
Patients often assume switching from semaglutide or tirzepatide to peptide blends is a simple medication change
Placebo-controlled clinical trials have shown that people who dont have diabetes lose an average of 15% from their baseline weight after taking Wegovy for 68 weeks compared to the 2.5% weight reduction in the placebo group
